The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Anti-Inflammatory Cytokine Market Research Report 2024

Global Anti-Inflammatory Cytokine Market Research Report 2024

Publishing Date : Sep, 2023

License Type :
 

Report Code : 1696755

No of Pages : 94

Synopsis
Anti-Inflammatory Cytokine is categorised as a large group of peptides, glycoproteins and proteins that are present into specific cells in the immune system. Cytokines are produced in the body may have different origins like lymphocytes, monocytes and others. Anti-inflammatory cytokines are regulatory molecule for a pro-inflammation response from cytokines. Inflammatory cytokines can lead to cytokine storm causing nerve-injury/inflammation-induced central sensitization, atherosclerosis or cancer. 
Global Anti-Inflammatory Cytokine market is projected to reach US$ 40060 million in 2029, increasing from US$ 25800 million in 2022, with the CAGR of 6.6% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Anti-Inflammatory Cytokine market research.
Key manufacturers engaged in the Anti-Inflammatory Cytokine industry include Merck KGaA, Eli Lilly and Company, Pfizer Inc., Sanofi S.A., Novartis AG, Hoffmann-La Roche Ltd., Lonza Group Ltd., Thermo Fisher Scientific and Meridian Bioscience Inc., etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Anti-Inflammatory Cytokine were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Anti-Inflammatory Cytokine market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Anti-Inflammatory Cytokine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Merck KGaA
Eli Lilly and Company
Pfizer Inc.
Sanofi S.A.
Novartis AG
Hoffmann-La Roche Ltd.
Lonza Group Ltd.
Thermo Fisher Scientific
Meridian Bioscience Inc.
General Electric Company
Abcam PLC
GenScript Biotech Corp
Applied Biological Materials Inc.
Randox Laboratories
Segment by Type
Oral
Intravenous
Others
Segment by Application
Cardiovascular Diseases
Osteoarthritis
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Anti-Inflammatory Cytokine report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index
1 Anti-Inflammatory Cytokine Market Overview
1.1 Product Overview and Scope of Anti-Inflammatory Cytokine
1.2 Anti-Inflammatory Cytokine Segment by Type
1.2.1 Global Anti-Inflammatory Cytokine Market Value Comparison by Type (2023-2029)
1.2.2 Oral
1.2.3 Intravenous
1.2.4 Others
1.3 Anti-Inflammatory Cytokine Segment by Application
1.3.1 Global Anti-Inflammatory Cytokine Market Value by Application: (2023-2029)
1.3.2 Cardiovascular Diseases
1.3.3 Osteoarthritis
1.3.4 Others
1.4 Global Anti-Inflammatory Cytokine Market Size Estimates and Forecasts
1.4.1 Global Anti-Inflammatory Cytokine Revenue 2018-2029
1.4.2 Global Anti-Inflammatory Cytokine Sales 2018-2029
1.4.3 Global Anti-Inflammatory Cytokine Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Anti-Inflammatory Cytokine Market Competition by Manufacturers
2.1 Global Anti-Inflammatory Cytokine Sales Market Share by Manufacturers (2018-2023)
2.2 Global Anti-Inflammatory Cytokine Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Anti-Inflammatory Cytokine Average Price by Manufacturers (2018-2023)
2.4 Global Anti-Inflammatory Cytokine Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Anti-Inflammatory Cytokine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Anti-Inflammatory Cytokine, Product Type & Application
2.7 Anti-Inflammatory Cytokine Market Competitive Situation and Trends
2.7.1 Anti-Inflammatory Cytokine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Anti-Inflammatory Cytokine Players Market Share by Revenue
2.7.3 Global Anti-Inflammatory Cytokine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Anti-Inflammatory Cytokine Retrospective Market Scenario by Region
3.1 Global Anti-Inflammatory Cytokine Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Anti-Inflammatory Cytokine Global Anti-Inflammatory Cytokine Sales by Region: 2018-2029
3.2.1 Global Anti-Inflammatory Cytokine Sales by Region: 2018-2023
3.2.2 Global Anti-Inflammatory Cytokine Sales by Region: 2024-2029
3.3 Global Anti-Inflammatory Cytokine Global Anti-Inflammatory Cytokine Revenue by Region: 2018-2029
3.3.1 Global Anti-Inflammatory Cytokine Revenue by Region: 2018-2023
3.3.2 Global Anti-Inflammatory Cytokine Revenue by Region: 2024-2029
3.4 North America Anti-Inflammatory Cytokine Market Facts & Figures by Country
3.4.1 North America Anti-Inflammatory Cytokine Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Anti-Inflammatory Cytokine Sales by Country (2018-2029)
3.4.3 North America Anti-Inflammatory Cytokine Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Anti-Inflammatory Cytokine Market Facts & Figures by Country
3.5.1 Europe Anti-Inflammatory Cytokine Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Anti-Inflammatory Cytokine Sales by Country (2018-2029)
3.5.3 Europe Anti-Inflammatory Cytokine Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Anti-Inflammatory Cytokine Market Facts & Figures by Country
3.6.1 Asia Pacific Anti-Inflammatory Cytokine Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Anti-Inflammatory Cytokine Sales by Country (2018-2029)
3.6.3 Asia Pacific Anti-Inflammatory Cytokine Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Anti-Inflammatory Cytokine Market Facts & Figures by Country
3.7.1 Latin America Anti-Inflammatory Cytokine Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Anti-Inflammatory Cytokine Sales by Country (2018-2029)
3.7.3 Latin America Anti-Inflammatory Cytokine Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Anti-Inflammatory Cytokine Market Facts & Figures by Country
3.8.1 Middle East and Africa Anti-Inflammatory Cytokine Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Anti-Inflammatory Cytokine Sales by Country (2018-2029)
3.8.3 Middle East and Africa Anti-Inflammatory Cytokine Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Anti-Inflammatory Cytokine Sales by Type (2018-2029)
4.1.1 Global Anti-Inflammatory Cytokine Sales by Type (2018-2023)
4.1.2 Global Anti-Inflammatory Cytokine Sales by Type (2024-2029)
4.1.3 Global Anti-Inflammatory Cytokine Sales Market Share by Type (2018-2029)
4.2 Global Anti-Inflammatory Cytokine Revenue by Type (2018-2029)
4.2.1 Global Anti-Inflammatory Cytokine Revenue by Type (2018-2023)
4.2.2 Global Anti-Inflammatory Cytokine Revenue by Type (2024-2029)
4.2.3 Global Anti-Inflammatory Cytokine Revenue Market Share by Type (2018-2029)
4.3 Global Anti-Inflammatory Cytokine Price by Type (2018-2029)
5 Segment by Application
5.1 Global Anti-Inflammatory Cytokine Sales by Application (2018-2029)
5.1.1 Global Anti-Inflammatory Cytokine Sales by Application (2018-2023)
5.1.2 Global Anti-Inflammatory Cytokine Sales by Application (2024-2029)
5.1.3 Global Anti-Inflammatory Cytokine Sales Market Share by Application (2018-2029)
5.2 Global Anti-Inflammatory Cytokine Revenue by Application (2018-2029)
5.2.1 Global Anti-Inflammatory Cytokine Revenue by Application (2018-2023)
5.2.2 Global Anti-Inflammatory Cytokine Revenue by Application (2024-2029)
5.2.3 Global Anti-Inflammatory Cytokine Revenue Market Share by Application (2018-2029)
5.3 Global Anti-Inflammatory Cytokine Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Merck KGaA
6.1.1 Merck KGaA Corporation Information
6.1.2 Merck KGaA Description and Business Overview
6.1.3 Merck KGaA Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Merck KGaA Anti-Inflammatory Cytokine Product Portfolio
6.1.5 Merck KGaA Recent Developments/Updates
6.2 Eli Lilly and Company
6.2.1 Eli Lilly and Company Corporation Information
6.2.2 Eli Lilly and Company Description and Business Overview
6.2.3 Eli Lilly and Company Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Eli Lilly and Company Anti-Inflammatory Cytokine Product Portfolio
6.2.5 Eli Lilly and Company Recent Developments/Updates
6.3 Pfizer Inc.
6.3.1 Pfizer Inc. Corporation Information
6.3.2 Pfizer Inc. Description and Business Overview
6.3.3 Pfizer Inc. Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Pfizer Inc. Anti-Inflammatory Cytokine Product Portfolio
6.3.5 Pfizer Inc. Recent Developments/Updates
6.4 Sanofi S.A.
6.4.1 Sanofi S.A. Corporation Information
6.4.2 Sanofi S.A. Description and Business Overview
6.4.3 Sanofi S.A. Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Sanofi S.A. Anti-Inflammatory Cytokine Product Portfolio
6.4.5 Sanofi S.A. Recent Developments/Updates
6.5 Novartis AG
6.5.1 Novartis AG Corporation Information
6.5.2 Novartis AG Description and Business Overview
6.5.3 Novartis AG Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Novartis AG Anti-Inflammatory Cytokine Product Portfolio
6.5.5 Novartis AG Recent Developments/Updates
6.6 Hoffmann-La Roche Ltd.
6.6.1 Hoffmann-La Roche Ltd. Corporation Information
6.6.2 Hoffmann-La Roche Ltd. Description and Business Overview
6.6.3 Hoffmann-La Roche Ltd. Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Hoffmann-La Roche Ltd. Anti-Inflammatory Cytokine Product Portfolio
6.6.5 Hoffmann-La Roche Ltd. Recent Developments/Updates
6.7 Lonza Group Ltd.
6.6.1 Lonza Group Ltd. Corporation Information
6.6.2 Lonza Group Ltd. Description and Business Overview
6.6.3 Lonza Group Ltd. Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Lonza Group Ltd. Anti-Inflammatory Cytokine Product Portfolio
6.7.5 Lonza Group Ltd. Recent Developments/Updates
6.8 Thermo Fisher Scientific
6.8.1 Thermo Fisher Scientific Corporation Information
6.8.2 Thermo Fisher Scientific Description and Business Overview
6.8.3 Thermo Fisher Scientific Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Thermo Fisher Scientific Anti-Inflammatory Cytokine Product Portfolio
6.8.5 Thermo Fisher Scientific Recent Developments/Updates
6.9 Meridian Bioscience Inc.
6.9.1 Meridian Bioscience Inc. Corporation Information
6.9.2 Meridian Bioscience Inc. Description and Business Overview
6.9.3 Meridian Bioscience Inc. Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Meridian Bioscience Inc. Anti-Inflammatory Cytokine Product Portfolio
6.9.5 Meridian Bioscience Inc. Recent Developments/Updates
6.10 General Electric Company
6.10.1 General Electric Company Corporation Information
6.10.2 General Electric Company Description and Business Overview
6.10.3 General Electric Company Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2018-2023)
6.10.4 General Electric Company Anti-Inflammatory Cytokine Product Portfolio
6.10.5 General Electric Company Recent Developments/Updates
6.11 Abcam PLC
6.11.1 Abcam PLC Corporation Information
6.11.2 Abcam PLC Anti-Inflammatory Cytokine Description and Business Overview
6.11.3 Abcam PLC Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Abcam PLC Anti-Inflammatory Cytokine Product Portfolio
6.11.5 Abcam PLC Recent Developments/Updates
6.12 GenScript Biotech Corp
6.12.1 GenScript Biotech Corp Corporation Information
6.12.2 GenScript Biotech Corp Anti-Inflammatory Cytokine Description and Business Overview
6.12.3 GenScript Biotech Corp Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2018-2023)
6.12.4 GenScript Biotech Corp Anti-Inflammatory Cytokine Product Portfolio
6.12.5 GenScript Biotech Corp Recent Developments/Updates
6.13 Applied Biological Materials Inc.
6.13.1 Applied Biological Materials Inc. Corporation Information
6.13.2 Applied Biological Materials Inc. Anti-Inflammatory Cytokine Description and Business Overview
6.13.3 Applied Biological Materials Inc. Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Applied Biological Materials Inc. Anti-Inflammatory Cytokine Product Portfolio
6.13.5 Applied Biological Materials Inc. Recent Developments/Updates
6.14 Randox Laboratories
6.14.1 Randox Laboratories Corporation Information
6.14.2 Randox Laboratories Anti-Inflammatory Cytokine Description and Business Overview
6.14.3 Randox Laboratories Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Randox Laboratories Anti-Inflammatory Cytokine Product Portfolio
6.14.5 Randox Laboratories Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Anti-Inflammatory Cytokine Industry Chain Analysis
7.2 Anti-Inflammatory Cytokine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Anti-Inflammatory Cytokine Production Mode & Process
7.4 Anti-Inflammatory Cytokine Sales and Marketing
7.4.1 Anti-Inflammatory Cytokine Sales Channels
7.4.2 Anti-Inflammatory Cytokine Distributors
7.5 Anti-Inflammatory Cytokine Customers
8 Anti-Inflammatory Cytokine Market Dynamics
8.1 Anti-Inflammatory Cytokine Industry Trends
8.2 Anti-Inflammatory Cytokine Market Drivers
8.3 Anti-Inflammatory Cytokine Market Challenges
8.4 Anti-Inflammatory Cytokine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’